Ennogen Receive £30 Million Credit Facility for Growth
Santander UK has provided Ennogen Healthcare International, a growing UK based pharmaceuticals manufacturer, with a £30 million loan facility to
May 11, 2024
Santander UK has provided Ennogen Healthcare International, a growing UK based pharmaceuticals manufacturer, with a £30 million loan facility to
Ribobay Pharma, a leading Chinese biopharmaceutical CRDMO and a spin-off company of General Biol (Anhui) Co., Ltd, will provide cGMP-level oligonucleotide
Regeneron Pharmaceuticals have announced that the investigational gene therapy DB-OTO improved hearing to normal levels in one child (dosed at 11
Teva Pharmaceuticals and Medincell have announced results from the efficacy portion of the Phase 3 Subcutaneous OLAnzapine extended-Release Injection Study
Pfizer have announced that Andrew Baum, M.D., will join the company as Chief Strategy and Innovation Officer, Executive Vice President.
Lantern Pharma have announced a strategic AI-driven collaboration with French biotechnology company, Oregon Therapeutics to optimise the development of its first-in-class protein disulfide isomerase
Sharp, a global leader in contract packaging, clinical supply services and small-scale sterile manufacturing, has announced plans for the expansion
Broken String Biosciences have announced it has entered a research collaboration with the Francis Crick Institute, a world-leading biomedical discovery
Johnson & Johnson have announced it is updating its brand and uniting both its two business segments under the Johnson
Merck is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In